Heart and cardiovascular health: Evidence-Based Supplement Guide

Heart health is the third most common reason people in Avelor hold a supplement: 19 of 72 people with a saved stack, across 20 saved items. It is also the area where the research has moved most in recent years, and where the honest summary is less encouraging than it was a decade ago. **Omega-3 is the most studied and the most argued about.** Large randomised trials and meta-analyses have examined cardiovascular outcomes (PMID 41201837, 33190147, 36501174), and the results do not all point the same way. The trial comparing high-dose omega-3 against corn oil (PMID 33190147) is the one that changed a lot of minds, because the comparator mattered. This guide does not tell you the question is settled, because it is not. **There is a documented harm signal as well as a benefit signal, and both are in the same literature.** Meta-analyses report increased atrial fibrillation with long-term marine omega-3 supplementation (PMID 34612056, 36103100). Anyone reading only the benefit half of this evidence is reading half of it. **CoQ10 has better evidence in heart failure specifically than in general heart health.** A randomised trial examined morbidity and mortality in chronic heart failure (PMID 25282031), and later reviews and meta-analyses have assessed it (PMID 35608922, 39462324). That is a specific diagnosed condition managed by a cardiologist, not a general wellness use. Separately, CoQ10 has been examined for statin-associated muscle symptoms (PMID 30371340, 41158831), where the reviews are more mixed than the marketing.

1. **If you have a diagnosed cardiac condition, this is a conversation with your cardiologist**, not a supplement decision. That is the step, not a preamble to one. 2. **If you are considering omega-3, read both halves of its evidence**: the cardiovascular outcome trials (PMID 41201837, 33190147) and the atrial-fibrillation signal (PMID 34612056). 3. **Tell whoever prescribes your medicines**, particularly if you take an anticoagulant or a statin.

The cardiovascular outcome trials ran for **years**, not weeks (PMID 33190147, 41201837). The heart failure trial reported over a **two-year** follow-up (PMID 25282031). Nothing in this guide has a short-term endpoint, which is itself worth knowing: the outcomes that matter here are not things you can feel changing.

- **The omega-3 evidence genuinely conflicts.** Different trials used different preparations, doses and comparators, and reached different conclusions. Presenting it as settled in either direction would misrepresent it. - **The atrial fibrillation signal is a real finding, not a caveat.** It appears in meta-analyses (PMID 34612056, 36103100) and belongs in the same sentence as any benefit claim. - **CoQ10's heart-failure evidence is in diagnosed heart failure.** Extending it to general cardiovascular wellness goes beyond the population studied. - **Red yeast rice contains monacolin K, which is chemically a statin** (PMID 33538260, 31687098). It is not a gentle alternative to one, and it is not dosed or standardised like one. - **No dose appears in this guide.** Dosing is a clinical decision and is held for clinician review. - **This guide has not been reviewed by a clinician.** `reviewStatus` above says so.

- **Omega-3 and warfarin: the evidence disagrees and you should know that it does.** There is a case report describing a serious bleeding outcome (PMID 28033135) and a pharmacokinetic study reporting no effect (PMID 28197979). Raise it with **the clinician who manages your anticoagulation** rather than deciding from either paper alone. - **Red yeast rice with a prescribed statin is additive**, because the active compound is a statin (PMID 33538260). Raise it with **the prescriber who manages your statin**. - **CoQ10 for statin muscle symptoms is not a reason to stop a statin.** Muscle symptoms on a statin are a conversation with **the prescribing clinician**, who has options that do not involve stopping treatment. - **New or worsening palpitations** should go to **a doctor**, particularly for anyone taking long-term omega-3, given the atrial fibrillation signal above.

| Entity ID | Name | | --- | --- | | `avelor:sup:omega-3` | Omega-3 (EPA/DHA) | | `avelor:sup:omega-3-fish-oil` | Omega-3 fish oil high-dose | | `avelor:sup:garlic` | Garlic high-dose extract | | `avelor:sup:hawthorn` | Hawthorn extract | | `avelor:sup:plant-sterols-and-stanols` | Plant sterols and stanols | | `avelor:sup:bergamot` | Bergamot extract | | `avelor:sup:berberine` | Berberine | **Named and not linkable.** **CoQ10** has no canonical entity, despite being one of the two compounds this guide is mostly about and appearing in live user stacks. **Red yeast rice** likewise has none, which matters more than usual because it is chemically a statin and is the entry most in need of interaction checking. Recorded here rather than linked to an invented ID. **Resolving is not the same as being checkable**, and this is the only guide so far where the distinction costs nothing. The interaction catalogue keys on a collapsed name string rather than an entity id, and all seven entities above happen to carry a catalogue key. That is the exception, not the pattern.

| PMID | Title | | --- | --- | | 41201837 | "Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis" | | 33190147 | "Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial" | | 36501174 | "Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health" | | 34612056 | "Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis" | | 36103100 | "Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis" | | 25282031 | "The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial" | | 35608922 | "Coenzyme Q10 for heart failure" | | 39462324 | "Efficacy and safety of coenzyme Q10 in heart failure: a meta-analysis of randomized controlled trials" | | 30371340 | "Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials" | | 41158831 | "Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis" | | 28033135 | "Omega-3 Fatty Acid Supplementation and Warfarin: A Lethal Combination in Traumatic Brain Injury" | | 28197979 | "No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers" | | 33538260 | "Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar" | | 31687098 | "Red Yeast Rice for Hypercholesterolemia" |